Skip to main content
Erschienen in: International Urology and Nephrology 10/2019

29.07.2019 | Nephrology - Original Paper

The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro

verfasst von: Tao Cao, Ricong Xu, Yi Xu, Yang Liu, Dongli Qi, Qijun Wan

Erschienen in: International Urology and Nephrology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetic nephropathy (DN) is one of the most serious chronic complications of diabetes mellitus (DM). Autophagy is an important physiological function for podocytes to maintain stability of intracellular environment. In this study, we planned to clarify the effect of Cordycepin, a traditional Chinese medicine, on DN and the related mechanisms.

Methods

All rats were randomly divided into normal control group, diabetic controls, low-dose group (10 mg/kg), medium-dose group (100 mg/kg), and high-dose group (500 mg/kg). The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein was examined through an automatic biochemistry analyser. Enzyme-linked immunosorbent assay (Elisa) was used to detect the level of IL-1β, IL-6, and IL-18. HE staining was used to examine histopathologic changes. TUNEL staining was used to detected cell apoptosis. The expression of fibrosis markers α-SMA, t-TG, and TIMP-1, apoptosis-related proteins cleaved-caspase3, Bax and Bcl-2, autophagy markers Beclin1, light chain 3 (LC3)I/II, and p62 were evaluated by western blot.

Results

The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein in the diabetic controls was much higher than that in the normal control group. Obvious histopathology injuries were also found in DN model group. After Cordycepin treatment, all the above indexes were improved compared with the DN group and tissue damages were also alleviated. Further studies showed that Cordycepin suppressed cell apoptosis and renal fibrosis and rescued cell autophagy in DN rat model. Moreover, the results of our in vitro experiments showed that the addition of 3-methyladenine (3-MA, specific autophagy inhibitor) successfully abolished the protective effect of Cordycepin on renal fibrosis through inducing apoptosis and renal fibrosis. The above protective effects of Cordycepin were exhibited in a dose-dependent manner.

Conclusion

Cordycepin participated in the modulation of cell apoptosis, fibrosis, and autophagy induction in DN. Our study for the first time revealed that Cordycepin had a certain therapeutic effect on DN in rats through autophagy induction.
Literatur
1.
Zurück zum Zitat Lasaridis AN, Sarafidis PA (2003) Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials? Am J Hypertens 16:689–697CrossRef Lasaridis AN, Sarafidis PA (2003) Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials? Am J Hypertens 16:689–697CrossRef
2.
Zurück zum Zitat Kume S, Kitada M, Kanasaki K, Maegawa H, Koya D (2013) Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res 36:230–236CrossRef Kume S, Kitada M, Kanasaki K, Maegawa H, Koya D (2013) Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res 36:230–236CrossRef
3.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRef Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRef
4.
Zurück zum Zitat Chen J, Zhao D, Zhu M, Zhang M, Hou X, Ding W, Sun S, Bu W, Feng L, Ma S, Jia X (2017) Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. Biomed Pharmacother 89:1362–1369CrossRef Chen J, Zhao D, Zhu M, Zhang M, Hou X, Ding W, Sun S, Bu W, Feng L, Ma S, Jia X (2017) Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. Biomed Pharmacother 89:1362–1369CrossRef
5.
Zurück zum Zitat Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME (2003) The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17:1762–1764CrossRef Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME (2003) The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17:1762–1764CrossRef
6.
Zurück zum Zitat Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRef Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRef
7.
Zurück zum Zitat Liang S, Jin J, Shen X, Jiang X, Li Y, He Q (2018) Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy. Exp Ther Med 16:2275–2280PubMedPubMedCentral Liang S, Jin J, Shen X, Jiang X, Li Y, He Q (2018) Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy. Exp Ther Med 16:2275–2280PubMedPubMedCentral
8.
Zurück zum Zitat Lennon MB, Suhadolnik RJ (1976) Biosynthesis of 3′-deoxyadenosine by Cordyceps militaris. Mechanism of reduction. Biochim Biophys Acta 425:532–536CrossRef Lennon MB, Suhadolnik RJ (1976) Biosynthesis of 3′-deoxyadenosine by Cordyceps militaris. Mechanism of reduction. Biochim Biophys Acta 425:532–536CrossRef
9.
Zurück zum Zitat Khan MA, Tania M (2018) Cordycepin in anticancer research: molecular mechanism of therapeutic effects. Curr Med Chem 22(3):1021–1027 Khan MA, Tania M (2018) Cordycepin in anticancer research: molecular mechanism of therapeutic effects. Curr Med Chem 22(3):1021–1027
10.
Zurück zum Zitat Li L, He D, Yang J, Wang X (2011) Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. J Pharmacol Sci 117:286–294CrossRef Li L, He D, Yang J, Wang X (2011) Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. J Pharmacol Sci 117:286–294CrossRef
11.
Zurück zum Zitat Ma L, Zhang S, Du M (2015) Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice. Nutr Res 35:431–439CrossRef Ma L, Zhang S, Du M (2015) Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice. Nutr Res 35:431–439CrossRef
12.
Zurück zum Zitat Yu SH, Dubey NK, Li WS, Liu MC, Chiang HS, Leu SJ, Shieh YH, Tsai FC, Deng WP (2016) Cordyceps militaris treatment preserves renal function in type 2 diabetic nephropathy mice. PLoS One 11:e0166342CrossRef Yu SH, Dubey NK, Li WS, Liu MC, Chiang HS, Leu SJ, Shieh YH, Tsai FC, Deng WP (2016) Cordyceps militaris treatment preserves renal function in type 2 diabetic nephropathy mice. PLoS One 11:e0166342CrossRef
13.
Zurück zum Zitat Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, Havel PJ, Raybould HE (2012) Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 302:R657–R666CrossRef Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, Havel PJ, Raybould HE (2012) Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 302:R657–R666CrossRef
14.
Zurück zum Zitat Isobe K, Adachi K, Hayashi S, Ito T, Miyoshi A, Kato A, Suzuki M (2012) Spontaneous glomerular and tubulointerstitial lesions in common marmosets (Callithrix jacchus). Vet Pathol 49:839–845CrossRef Isobe K, Adachi K, Hayashi S, Ito T, Miyoshi A, Kato A, Suzuki M (2012) Spontaneous glomerular and tubulointerstitial lesions in common marmosets (Callithrix jacchus). Vet Pathol 49:839–845CrossRef
15.
Zurück zum Zitat Liu WY, Wang ZB, Wang Y, Tong LC, Li Y, Wei X, Luan P, Li L (2015) Increasing the permeability of the blood–brain barrier in three different models in vivo. CNS Neurosci Ther 21:568–574CrossRef Liu WY, Wang ZB, Wang Y, Tong LC, Li Y, Wei X, Luan P, Li L (2015) Increasing the permeability of the blood–brain barrier in three different models in vivo. CNS Neurosci Ther 21:568–574CrossRef
16.
Zurück zum Zitat Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH (2017) Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2alpha-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin 38:1129–1140CrossRef Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH (2017) Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2alpha-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin 38:1129–1140CrossRef
17.
Zurück zum Zitat Geletu AH, Teferra AS, Sisay MM, Teshome DF (2018) Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa. Ethiopia. BMC Res Notes 11:532CrossRef Geletu AH, Teferra AS, Sisay MM, Teshome DF (2018) Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa. Ethiopia. BMC Res Notes 11:532CrossRef
18.
Zurück zum Zitat Hu P, Chen W, Bao J, Jiang L, Wu L (2014) Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study. Int J Clin Exp Pathol 7:6575–6584PubMedPubMedCentral Hu P, Chen W, Bao J, Jiang L, Wu L (2014) Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study. Int J Clin Exp Pathol 7:6575–6584PubMedPubMedCentral
19.
Zurück zum Zitat Liang SM, Lu YJ, Ko BS, Jan YJ, Shyue SK, Yet SF, Liou JY (2017) Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity. Sci Rep 7:43930CrossRef Liang SM, Lu YJ, Ko BS, Jan YJ, Shyue SK, Yet SF, Liou JY (2017) Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity. Sci Rep 7:43930CrossRef
20.
Zurück zum Zitat Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, Jiao C, Zuo D (2018) Cordycepin, a characteristic bioactive constituent in Cordyceps militaris, ameliorates hyperuricemia through URAT1 in hyperuricemic mice. Front Microbiol 9:58CrossRef Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, Jiao C, Zuo D (2018) Cordycepin, a characteristic bioactive constituent in Cordyceps militaris, ameliorates hyperuricemia through URAT1 in hyperuricemic mice. Front Microbiol 9:58CrossRef
21.
Zurück zum Zitat Sun T, Dong W, Jiang G, Yang J, Liu J, Zhao L, Ma P (2019) Cordyceps militaris improves chronic kidney disease by affecting TLR4/NF-kappaB redox signaling pathway. Oxid Med Cell Longev 2019:7850863PubMedPubMedCentral Sun T, Dong W, Jiang G, Yang J, Liu J, Zhao L, Ma P (2019) Cordyceps militaris improves chronic kidney disease by affecting TLR4/NF-kappaB redox signaling pathway. Oxid Med Cell Longev 2019:7850863PubMedPubMedCentral
22.
Zurück zum Zitat Hong T, Cui LK, Wen J, Zhang MH, Fan JM (2015) Cordycepin protects podocytes from injury mediated by complements complex C5b-9. Sichuan Da Xue Xue Bao Yi Xue Ban 46(173):178 (227) Hong T, Cui LK, Wen J, Zhang MH, Fan JM (2015) Cordycepin protects podocytes from injury mediated by complements complex C5b-9. Sichuan Da Xue Xue Bao Yi Xue Ban 46(173):178 (227)
23.
Zurück zum Zitat Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K (2009) Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9:98–105CrossRef Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K (2009) Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9:98–105CrossRef
24.
Zurück zum Zitat Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65:755–767CrossRef Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65:755–767CrossRef
25.
Zurück zum Zitat Zhang Y, Zhao S, Wu D, Liu X, Shi M, Wang Y, Zhang F, Ding J, Xiao Y (2018) MicroRNA-22 promotes renal tubulointerstitial fibrosis by targeting PTEN and suppressing autophagy in diabetic nephropathy. J Diabetes Res 2018:4728645PubMedPubMedCentral Zhang Y, Zhao S, Wu D, Liu X, Shi M, Wang Y, Zhang F, Ding J, Xiao Y (2018) MicroRNA-22 promotes renal tubulointerstitial fibrosis by targeting PTEN and suppressing autophagy in diabetic nephropathy. J Diabetes Res 2018:4728645PubMedPubMedCentral
26.
Zurück zum Zitat Gong J, Jin J, Zhao L, Li Y, Li Y, He Q (2018) Tripterygium glycoside protects against puromycin amino nucleoside induced podocyte injury by upregulating autophagy. Int J Mol Med 42:115–122PubMedPubMedCentral Gong J, Jin J, Zhao L, Li Y, Li Y, He Q (2018) Tripterygium glycoside protects against puromycin amino nucleoside induced podocyte injury by upregulating autophagy. Int J Mol Med 42:115–122PubMedPubMedCentral
Metadaten
Titel
The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro
verfasst von
Tao Cao
Ricong Xu
Yi Xu
Yang Liu
Dongli Qi
Qijun Wan
Publikationsdatum
29.07.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02241-y

Weitere Artikel der Ausgabe 10/2019

International Urology and Nephrology 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.